Questions grow over health of Iran’s supreme leader Mojtaba Khamenei after airstrike

Questions grow over health of Iran’s supreme leader Mojtaba Khamenei after airstrike

Washington: United States President Donald J. Trump said he believes Iran’s newly appointed supreme leader Mojtaba Khamenei is still alive but may be seriously injured following a recent airstrike during the ongoing conflict in the Middle East.

Speaking to reporters, Trump said the Iranian leader is probably alive but “damaged,” suggesting that he may have suffered significant injuries in the attack. His remarks came as speculation continues about the health of Mojtaba Khamenei, who was recently elevated to the top leadership position in Iran.

Several media reports have claimed that Mojtaba Khamenei was injured in an airstrike that targeted key locations in Iran. Some unconfirmed reports suggest that he may have lost a leg in the attack and is currently in critical condition. However, Iranian authorities have not officially confirmed these claims.

Since his reported appointment as supreme leader, Mojtaba Khamenei has not appeared publicly. Messages attributed to him have been delivered through state television presenters rather than in person, which has further fueled questions about his health and ability to lead.

The situation comes amid rising tensions between Iran and the United States and its allies. Recent weeks have seen a series of military strikes, drone attacks, and threats of retaliation across the region, raising fears of a wider conflict in the Middle East.

Analysts say uncertainty surrounding the condition of Iran’s new leader could further complicate the already tense situation. Until Iranian officials provide clear information, speculation about his health and leadership is likely to continue.


Follow the CNewsLive English Readers channel on WhatsApp:
https://whatsapp.com/channel/0029Vaz4fX77oQhU1lSymM1w

The comments posted here are not from Cnews Live. Kindly refrain from using derogatory, personal, or obscene words in your comments.